FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Gastric cancer is a leading cause of cancer mortality worldwide.
• Upregulated cyclooxygenase-2 (COX2) is implicated in gastric cancer development.
• The precise regulatory mechanisms of COX2 in gastric cancer remain largely unknown.

Purpose of the Study:

• To elucidate the regulatory mechanisms of COX2 during gastric cancer progression.
• To investigate the role of nuclear factor kappa B (NF-κB) and its relationship with COX2.
• To identify novel regulators of NF-κB activity in gastric cancer.

Main Methods:

• Correlation analysis between COX2 expression and NF-κB activity.
• Assessment of NF-κB nuclear localization versus transcriptional activity.
• Investigation of Forkhead box protein 3 (FOXP3) expression and its interaction with NF-κB.
• FOXP3 knockdown experiments to evaluate effects on NF-κB, COX2, and cell migration.

Main Results:

• COX2 expression positively correlated with NF-κB activity.
• NF-κB nuclear localization did not always align with its transcriptional activity.
• FOXP3 expression inversely correlated with NF-κB activity, interacting with NF-κB to repress its function.
• FOXP3 knockdown led to increased NF-κB activity, elevated COX2 expression, and enhanced cell migration.

Conclusions:

• FOXP3 functions as a negative regulator of NF-κB activity in gastric cancer.
• FOXP3 exerts a tumor suppressor role by inhibiting NF-κB-mediated COX2 expression.
• Targeting FOXP3-NF-κB pathway may offer therapeutic strategies for reducing gastric cancer metastasis.